Editas Medicine (EDIT) announced the appointment of current Independent Director Emma Reeve as Chair of the Board, effective at the Company’s next annual stockholder meeting, currently scheduled for June 1. Reeve will be replacing James Mullen as he steps down from the Board and his role as Executive Chair. The Company also announced the appointment of Elliott Levy, M.D., to its Board of Directors as an independent director. Most recently, Reeve served as Chief Financial Officer of Constellation Pharmaceuticals. Dr. Levy served as Senior Vice President and Head of Global Development and R&D Strategy and Operations at Amgen (AMGN) from 2014-2021.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EDIT:
- Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director
- Stifel says SVB fallout ‘appears limited’ across firm’s biotech coverage
- Editas Medicine announces appointment of Aspesi as EVP, CPO
- Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer
- Editas Medicine price target lowered to $22 from $35 at Chardan
